This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nakamura, S.
Right arrow Articles by Mukhopadhyay, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nakamura, S.
Right arrow Articles by Mukhopadhyay, T.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, December 2000, p. 9391-9398, Vol. 20, No. 24
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

Multiple Lysine Mutations in the C-Terminal Domain of p53 Interfere with MDM2-Dependent Protein Degradation and Ubiquitination

Seiichi Nakamura,1 Jack A. Roth,1,2 and Tapas Mukhopadhyay1,*

Section of Thoracic Molecular Oncology, Departments of Thoracic and Cardiovascular Surgery1 and Tumor Biology,2 The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030

Received 18 February 2000/Returned for modification 4 April 2000/Accepted 11 September 2000

To investigate the effect of mutations in the p53 C-terminal domain on MDM2-mediated degradation, we introduced single and multiple point mutations into a human p53 cDNA at four putative acetylation sites (amino acid residues 372, 373, 381, and 382). Substitution of all four lysine residues by alanines (the A4 mutant) and single lysine-to-alanine substitutions were functional in sequence-specific DNA binding and transactivation; however, the A4 mutant protein was resistant to MDM2-mediated degradation, whereas the single lysine substitutions were not. Although the A4 mutant protein and the single lysine substitutions both bound MDM2 reasonably well, the single lysine substitutions underwent normal MDM2-dependent ubiquitination, whereas the A4 protein was inefficiently ubiquitinated. In addition, the A4 mutant protein was found in the cytoplasm as well as in the nucleus of a subpopulation of cells, unlike wild-type p53, which is mostly nuclear. The partially cytoplasmic distribution of A4 mutant protein was not due to a defect in nuclear import because inhibition of nuclear export by leptomycin B resulted in nuclear accumulation of the protein. Taken together, the data suggest that mutations in the putative acetylation sites of the p53 C-terminal domain interfere with ubiquitination, thereby regulating p53 degradation.


* Corresponding author. Mailing address: Department of Thoracic and Cardiovascular Surgery, Box 109, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030. Phone: (713) 745-4542. Fax: (713) 794-4901. E-mail: tmukhopa{at}notes.mdacc.tmc.edu.


Molecular and Cellular Biology, December 2000, p. 9391-9398, Vol. 20, No. 24
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Kim, H. S., Lim, I. K. (2009). Phosphorylated Extracellular Signal-regulated Protein Kinases 1 and 2 Phosphorylate Sp1 on Serine 59 and Regulate Cellular Senescence via Transcription of p21Sdi1/Cip1/Waf1. J. Biol. Chem. 284: 15475-15486 [Abstract] [Full Text]  
  • Itahana, Y., Ke, H., Zhang, Y. (2009). p53 Oligomerization Is Essential for Its C-terminal Lysine Acetylation. J. Biol. Chem. 284: 5158-5164 [Abstract] [Full Text]  
  • Kruse, J.-P., Gu, W. (2009). MSL2 Promotes Mdm2-independent Cytoplasmic Localization of p53. J. Biol. Chem. 284: 3250-3263 [Abstract] [Full Text]  
  • Brooks, C. L., Li, M., Gu, W. (2007). Mechanistic Studies of MDM2-mediated Ubiquitination in p53 Regulation. J. Biol. Chem. 282: 22804-22815 [Abstract] [Full Text]  
  • van der Veer, E., Ho, C., O'Neil, C., Barbosa, N., Scott, R., Cregan, S. P., Pickering, J. G. (2007). Extension of Human Cell Lifespan by Nicotinamide Phosphoribosyltransferase. J. Biol. Chem. 282: 10841-10845 [Abstract] [Full Text]  
  • Abida, W. M., Nikolaev, A., Zhao, W., Zhang, W., Gu, W. (2007). FBXO11 Promotes the Neddylation of p53 and Inhibits Its Transcriptional Activity. J. Biol. Chem. 282: 1797-1804 [Abstract] [Full Text]  
  • Chao, C., Wu, Z., Mazur, S. J., Borges, H., Rossi, M., Lin, T., Wang, J. Y. J., Anderson, C. W., Appella, E., Xu, Y. (2006). Acetylation of Mouse p53 at Lysine 317 Negatively Regulates p53 Apoptotic Activities after DNA Damage.. Mol. Cell. Biol. 26: 6859-6869 [Abstract] [Full Text]  
  • Ohkubo, S., Tanaka, T., Taya, Y., Kitazato, K., Prives, C. (2006). Excess HDM2 Impacts Cell Cycle and Apoptosis and Has a Selective Effect on p53-dependent Transcription. J. Biol. Chem. 281: 16943-16950 [Abstract] [Full Text]  
  • Ju, D., Xie, Y. (2006). Identification of the Preferential Ubiquitination Site and Ubiquitin-dependent Degradation Signal of Rpn4. J. Biol. Chem. 281: 10657-10662 [Abstract] [Full Text]  
  • White, D. E., Talbott, K. E., Arva, N. C., Bargonetti, J. (2006). Mouse Double Minute 2 Associates with Chromatin in the Presence of p53 and Is Released to Facilitate Activation of Transcription.. Cancer Res. 66: 3463-3470 [Abstract] [Full Text]  
  • Allen, T., van Tuyl, M., Iyengar, P., Jothy, S., Post, M., Tsao, M.-S., Lobe, C. G. (2006). Grg1 Acts as a Lung-Specific Oncogene in a Transgenic Mouse Model. Cancer Res. 66: 1294-1301 [Abstract] [Full Text]  
  • Chan, W. M., Mak, M. C., Fung, T. K., Lau, A., Siu, W. Y., Poon, R. Y.C. (2006). Ubiquitination of p53 at Multiple Sites in the DNA-Binding Domain. Mol Cancer Res 4: 15-25 [Abstract] [Full Text]  
  • Perrot, V., Rechler, M. M. (2005). The Coactivator p300 Directly Acetylates the Forkhead Transcription Factor Foxo1 and Stimulates Foxo1-Induced Transcription. Mol. Endocrinol. 19: 2283-2298 [Abstract] [Full Text]  
  • Feng, L., Lin, T., Uranishi, H., Gu, W., Xu, Y. (2005). Functional Analysis of the Roles of Posttranslational Modifications at the p53 C Terminus in Regulating p53 Stability and Activity. Mol. Cell. Biol. 25: 5389-5395 [Abstract] [Full Text]  
  • Allison, S. J., Milner, J. (2004). Remodelling chromatin on a global scale: a novel protective function of p53. Carcinogenesis 25: 1551-1557 [Abstract] [Full Text]  
  • Danovi, D., Meulmeester, E., Pasini, D., Migliorini, D., Capra, M., Frenk, R., de Graaf, P., Francoz, S., Gasparini, P., Gobbi, A., Helin, K., Pelicci, P. G., Jochemsen, A. G., Marine, J.-C. (2004). Amplification of Mdmx (or Mdm4) Directly Contributes to Tumor Formation by Inhibiting p53 Tumor Suppressor Activity. Mol. Cell. Biol. 24: 5835-5843 [Abstract] [Full Text]  
  • Iyer, N. G., Chin, S.-F., Ozdag, H., Daigo, Y., Hu, D.-E., Cariati, M., Brindle, K., Aparicio, S., Caldas, C. (2004). p300 regulates p53-dependent apoptosis after DNA damage in colorectal cancer cells by modulation of PUMA/p21 levels. Proc. Natl. Acad. Sci. USA 101: 7386-7391 [Abstract] [Full Text]  
  • Luo, J., Li, M., Tang, Y., Laszkowska, M., Roeder, R. G., Gu, W. (2004). Acetylation of p53 augments its site-specific DNA binding both in vitro and in vivo. Proc. Natl. Acad. Sci. USA 101: 2259-2264 [Abstract] [Full Text]  
  • Qu, L., Huang, S., Baltzis, D., Rivas-Estilla, A.-M., Pluquet, O., Hatzoglou, M., Koumenis, C., Taya, Y., Yoshimura, A., Koromilas, A. E. (2004). Endoplasmic reticulum stress induces p53 cytoplasmic localization and prevents p53-dependent apoptosis by a pathway involving glycogen synthase kinase-3{beta}. Genes Dev. 18: 261-277 [Abstract] [Full Text]  
  • Ohtani, S., Kagawa, S., Tango, Y., Umeoka, T., Tokunaga, N., Tsunemitsu, Y., Roth, J. A., Taya, Y., Tanaka, N., Fujiwara, T. (2004). Quantitative analysis of p53-targeted gene expression and visualization of p53 transcriptional activity following intratumoral administration of adenoviral p53 in vivo. Molecular Cancer Therapeutics 3: 93-100 [Abstract] [Full Text]  
  • Terui, T., Murakami, K., Takimoto, R., Takahashi, M., Takada, K., Murakami, T., Minami, S., Matsunaga, T., Takayama, T., Kato, J., Niitsu, Y. (2003). Induction of PIG3 and NOXA through Acetylation of p53 at 320 and 373 Lysine Residues as a Mechanism for Apoptotic Cell Death by Histone Deacetylase Inhibitors. Cancer Res. 63: 8948-8954 [Abstract] [Full Text]  
  • Li, M., Brooks, C. L., Wu-Baer, F., Chen, D., Baer, R., Gu, W. (2003). Mono- Versus Polyubiquitination: Differential Control of p53 Fate by Mdm2. Science 302: 1972-1975 [Abstract] [Full Text]  
  • Iwakuma, T., Lozano, G. (2003). MDM2, An Introduction. Mol Cancer Res 1: 993-1000 [Abstract] [Full Text]  
  • Sah, N. K., Munshi, A., Nishikawa, T., Mukhopadhyay, T., Roth, J. A., Meyn, R. E. (2003). Adenovirus-mediated wild-type p53 radiosensitizes human tumor cells by suppressing DNA repair capacity. Molecular Cancer Therapeutics 2: 1223-1231 [Abstract] [Full Text]  
  • Zeng, L., Zhang, Y., Chien, S., Liu, X., Shyy, J. Y.-J. (2003). The Role of p53 Deacetylation in p21Waf1 Regulation by Laminar Flow. J. Biol. Chem. 278: 24594-24599 [Abstract] [Full Text]  
  • Shiseki, M., Nagashima, M., Pedeux, R. M., Kitahama-Shiseki, M., Miura, K., Okamura, S., Onogi, H., Higashimoto, Y., Appella, E., Yokota, J., Harris, C. C. (2003). p29ING4 and p28ING5 Bind to p53 and p300, and Enhance p53 Activity. Cancer Res. 63: 2373-2378 [Abstract] [Full Text]  
  • Lagger, G., Doetzlhofer, A., Schuettengruber, B., Haidweger, E., Simboeck, E., Tischler, J., Chiocca, S., Suske, G., Rotheneder, H., Wintersberger, E., Seiser, C. (2003). The Tumor Suppressor p53 and Histone Deacetylase 1 Are Antagonistic Regulators of the Cyclin-Dependent Kinase Inhibitor p21/WAF1/CIP1 Gene. Mol. Cell. Biol. 23: 2669-2679 [Abstract] [Full Text]  
  • Giandomenico, V., Simonsson, M., Gronroos, E., Ericsson, J. (2003). Coactivator-Dependent Acetylation Stabilizes Members of the SREBP Family of Transcription Factors. Mol. Cell. Biol. 23: 2587-2599 [Abstract] [Full Text]  
  • Zeng, S. X., Jin, Y., Kuninger, D. T., Rotwein, P., Lu, H. (2003). The Acetylase Activity of p300 Is Dispensable for MDM2 Stabilization. J. Biol. Chem. 278: 7453-7458 [Abstract] [Full Text]  
  • Li, M., Luo, J., Brooks, C. L., Gu, W. (2002). Acetylation of p53 Inhibits Its Ubiquitination by Mdm2. J. Biol. Chem. 277: 50607-50611 [Abstract] [Full Text]  
  • Sasaki, J.-i., Ramesh, R., Chada, S., Gomyo, Y., Roth, J. A., Mukhopadhyay, T. (2002). The Anthelmintic Drug Mebendazole Induces Mitotic Arrest and Apoptosis by Depolymerizing Tubulin in Non-Small Cell Lung Cancer Cells. Molecular Cancer Therapeutics 1: 1201-1209 [Abstract] [Full Text]  
  • Mukhopadhyay, T., Sasaki, J.-i., Ramesh, R., Roth, J. A. (2002). Mebendazole Elicits a Potent Antitumor Effect on Human Cancer Cell Lines Both in Vitro and in Vivo. Clin. Cancer Res. 8: 2963-2969 [Abstract] [Full Text]  
  • Jin, Y., Zeng, S. X., Dai, M.-S., Yang, X.-J., Lu, H. (2002). MDM2 Inhibits PCAF (p300/CREB-binding Protein-associated Factor)-mediated p53 Acetylation. J. Biol. Chem. 277: 30838-30843 [Abstract] [Full Text]  
  • Ard, P. G., Chatterjee, C., Kunjibettu, S., Adside, L. R., Gralinski, L. E., McMahon, S. B. (2002). Transcriptional Regulation of the mdm2 Oncogene by p53 Requires TRRAP Acetyltransferase Complexes. Mol. Cell. Biol. 22: 5650-5661 [Abstract] [Full Text]  
  • Glickman, M. H., Ciechanover, A. (2002). The Ubiquitin-Proteasome Proteolytic Pathway: Destruction for the Sake of Construction. Physiol. Rev. 82: 373-428 [Abstract] [Full Text]  
  • Yan, C., Wang, H., Boyd, D. D. (2002). ATF3 Represses 72-kDa Type IV Collagenase (MMP-2) Expression by Antagonizing p53-dependent trans-Activation of the Collagenase Promoter. J. Biol. Chem. 277: 10804-10812 [Abstract] [Full Text]  
  • Lohrum, M. A. E., Woods, D. B., Ludwig, R. L., Balint, E., Vousden, K. H. (2001). C-Terminal Ubiquitination of p53 Contributes to Nuclear Export. Mol. Cell. Biol. 21: 8521-8532 [Abstract] [Full Text]  
  • Gu, J., Nie, L., Wiederschain, D., Yuan, Z.-M. (2001). Identification of p53 Sequence Elements That Are Required for MDM2-Mediated Nuclear Export. Mol. Cell. Biol. 21: 8533-8546 [Abstract] [Full Text]  
  • Bai, L., Merchant, J. L. (2001). ZBP-89 Promotes Growth Arrest through Stabilization of p53. Mol. Cell. Biol. 21: 4670-4683 [Abstract] [Full Text]  
  • Zhang, Y., Xiong, Y. (2001). Control of p53 Ubiquitination and Nuclear Export by MDM2 and ARF. Cell Growth Differ. 12: 175-186 [Abstract] [Full Text]  
  • Lai, Z., Ferry, K. V., Diamond, M. A., Wee, K. E., Kim, Y. B., Ma, J., Yang, T., Benfield, P. A., Copeland, R. A., Auger, K. R. (2001). Human mdm2 Mediates Multiple Mono-ubiquitination of p53 by a Mechanism Requiring Enzyme Isomerization. J. Biol. Chem. 276: 31357-31367 [Abstract] [Full Text]  
  • Hu, Z.-Z., Meng, J., Dufau, M. L. (2001). Isolation and Characterization of Two Novel Forms of the Human Prolactin Receptor Generated by Alternative Splicing of a Newly Identified Exon 11. J. Biol. Chem. 276: 41086-41094 [Abstract] [Full Text]  
  • Chernov, M. V., Bean, L. J. H., Lerner, N., Stark, G. R. (2001). Regulation of Ubiquitination and Degradation of p53 in Unstressed Cells through C-terminal Phosphorylation. J. Biol. Chem. 276: 31819-31824 [Abstract] [Full Text]